Browsing by Author Meagher N

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Publication DateTitleAuthor(s)TypeSubject
17-Feb-2022Clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation (CASSETTE)-an open-labelled pilot randomized controlled trial.Campbell AJ; Dotel R; Braddick M; Britton PN; Eisen DP; Francis JR; Lynar S; McMullan B; Meagher N; Nelson J; O'Sullivan MVN; Price DJ; Robinson JO; Whelan A; Tong SYC; Bowen AC; Davis JSJournal Article- 
19-Nov-2022Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.Legg A; Meagher N; Johnson SA; Roberts MA; Cass A; Scheetz MH; Davies J; Roberts JA; Davis JS; Tong SYCPublished Erratum- 
11-Feb-2020Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JSJournal Article- 
10-Oct-2022Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.Legg A; Meagher N; Johnson SA; Roberts MA; Cass A; Scheetz MH; Davies J; Roberts JA; Davis JS; Tong SYCJournal Article-